National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI

What You Need To Know About™

Melanoma

    Posted: 03/31/2003



Introduction






What Is Melanoma?






The Skin






Melanocytes and Moles






Understanding Cancer






Melanoma






Melanoma: Who’s at Risk?






Signs and Symptoms






Dysplastic Nevi






Diagnosis






Staging






Stages of Melanoma






Treatment






Getting a Second Opinion






Preparing for Treatment






Methods of Treatment






Surgery






Chemotherapy






Biological Therapy






Radiation Therapy






Treatment Choices by Stage






Recurrent Melanoma






Side Effects of Treatment






Surgery






Chemotherapy






Biological Therapy






Radiation Therapy






Nutrition






Followup Care






Support for People with Melanoma






The Promise of Cancer Research






How To Do a Skin Self-Exam






National Cancer Institute Booklets






National Cancer Institute Information Resources



Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Order Free Copy
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
The Promise of Cancer Research

Doctors all over the country are conducting many types of clinical trials. These are research studies in which people take part voluntarily. Studies include new ways to treat melanomas. Research already has led to advances, and researchers continue to search for more effective approaches.

Patients who join these studies have the first chance to benefit from treatments that have shown promise in earlier research. They also make an important contribution to medical science by helping doctors learn more about the disease. Although clinical trials may pose some risks, researchers take very careful steps to protect their patients.

Researchers are testing new anticancer drugs. They are looking at combining chemotherapy with radiation therapy. Other studies are combining chemotherapy with biological therapy. Scientists also are studying several cancer vaccines and a type of gene therapy designed to help the immune system kill cancer cells.

Patients who are interested in being part of a clinical trial should talk with their doctor. They may want to read the NCI booklet Taking Part in Cancer Treatment Research Studies. It explains how clinical trials are carried out and explains their possible benefits and risks. NCI’s Web site includes a section on clinical trials at http://www.cancer.gov/clinicaltrials. This section of the Web site provides general information about clinical trials. It also offers detailed information about ongoing studies of melanoma treatment by linking to PDQ®, a cancer information database developed by the NCI. The Cancer Information Service at 1-800-4-CANCER can answer questions and provide information from the PDQ database.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov